Negative regulation of TBK1-mediated antiviral immunity

FEBS Letters

Volumn 587, Issue 6, 2013, Pages 542-548

  Zhao, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Antiviral; Interferon; TBK1; Virus

Indexed keywords

2,4 DIAMINO 5 CYCLOPROPYLPYRIMIDINE DERIVATIVE; ALPHA INTERFERON; AZABENZIMIDAZOLE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BETA INTERFERON; BX 795; I KAPPA B KINASE; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; ORANTINIB; PYRIMIDINE DERIVATIVE; TANK BINDING KINASE 1; TANK BINDING KINASE 1 INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; APOPTOSIS; AUTOPHAGY; CARCINOGENESIS; CELL TRANSFORMATION; COMPLEX FORMATION; ENZYME ACTIVITY; GENE REARRANGEMENT; IMMUNE EVASION; INNATE IMMUNITY; INTERFERON INDUCTION; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; MICE; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; VIRUS DISEASES; VIRUSES;

EID: 84875219325     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.01.052     Document Type: Review

References (109)

1. J.L. Pomerantz, and D. Baltimore NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase EMBO J. 18 1999 6694 6704
2. Y. Tojima, A. Fujimoto, M. Delhase, Y. Chen, S. Hatakeyama, K. Nakayama, Y. Kaneko, Y. Nimura, N. Motoyama, K. Ikeda, M. Karin, and M. Nakanishi NAK is an IkappaB kinase-activating kinase Nature 404 2000 778 782
3. R.T. Peters, S.M. Liao, and T. Maniatis IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex Mol. Cell. 5 2000 513 522
4. N. Kishore, Q.K. Huynh, S. Mathialagan, T. Hall, S. Rouw, D. Creely, G. Lange, J. Caroll, B. Reitz, A. Donnelly, H. Boddupalli, R.G. Combs, K. Kretzmer, and C.S. Tripp IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2 J. Biol. Chem. 277 2002 13840 13847
5. K. Clark, M. Peggie, L. Plater, R.J. Sorcek, E.R. Young, J.B. Madwed, J. Hough, E.G. McIver, and P. Cohen Novel cross-talk within the IKK family controls innate immunity Biochem. J. 434 2011 93 104
6. S.M. McWhirter, K.A. Fitzgerald, J. Rosains, D.C. Rowe, D.T. Golenbock, and T. Maniatis IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts Proc. Natl. Acad. Sci. USA 101 2004 233 238
7. H. Hemmi, O. Takeuchi, S. Sato, M. Yamamoto, T. Kaisho, H. Sanjo, T. Kawai, K. Hoshino, K. Takeda, and S. Akira The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection J. Exp. Med. 199 2004 1641 1650
8. K.A. Fitzgerald, S.M. McWhirter, K.L. Faia, D.C. Rowe, E. Latz, D.T. Golenbock, A.J. Coyle, S.M. Liao, and T. Maniatis IKKε and TBK1 are essential components of the IRF3 signaling pathway Nat. Immunol. 4 2003 491 496
9. S. Sharma, B.R. tenOever, N. Grandvaux, G.P. Zhou, R. Lin, and J. Hiscott Triggering the interferon antiviral response through an IKK-related pathway Science 300 2003 1148 1151
10. A.K. Perry, E.K. Chow, J.B. Goodnough, W.C. Yeh, and G. Cheng Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection J. Exp. Med. 199 2004 1651 1658
11. T. Yu, Y.S. Yi, Y. Yang, J. Oh, D. Jeong, and J.Y. Cho The pivotal role of TBK1 in inflammatory responses mediated by macrophages Mediators Inflamm. 2012 2012 979105
12. D.B. Stetson, and R. Medzhitov Antiviral defense: interferons and beyond J. Exp. Med. 203 2006 1837 1841
13. A.N. Theofilopoulos, R. Baccala, B. Beutler, and D.H. Kono Type I interferons (alpha/beta) in immunity and autoimmunity Annu. Rev. Immunol. 23 2005 307 336
14. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 2001 732 738
15. M. Yoneyama, M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses Nat. Immunol. 5 2004 730 737
16. V. Hornung, J. Ellegast, S. Kim, K. Brzózka, A. Jung, H. Kato, H. Poeck, S. Akira, K.K. Conzelmann, M. Schlee, S. Endres, and G. Hartmann 5′-Triphosphate RNA is the ligand for RIG-I Science 314 2006 994 997
17. A. Pichlmair, O. Schulz, C.P. Tan, T.I. Näslund, P. Liljeström, F. Weber, and C. Reis e Sousa RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates Science 314 2006 997 1001
18. H. Kato, O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K.J. Ishii, O. Yamaguchi, K. Otsu, T. Tsujimura, C.S. Koh, C. Reis e Sousa, Y. Matsuura, T. Fujita, and S. Akira Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses Nature 441 2006 101 105
19. A. Sabbah, T.H. Chang, R. Harnack, V. Frohlich, K. Tominaga, P.H. Dube, Y. Xiang, and S. Bose Activation of innate immune antiviral responses by Nod2 Nat. Immunol. 10 2009 1073 1080
20. A. Ablasser, F. Bauernfeind, G. Hartmann, E. Latz, K.A. Fitzgerald, and V. Hornung RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate Nat. Immunol. 10 2009 1065 1072
21. Y.H. Chiu, J.B. Macmillan, and Z.J. Chen RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway Cell Signal. 138 2009 576 591
22. A. Takaoka, Z. Wang, M.K. Choi, H. Yanai, H. Negishi, T. Ban, Y. Lu, M. Miyagishi, T. Kodama, K. Honda, Y. Ohba, and T. Taniguchi DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response Nature 448 2007 501 505
23. L. Unterholzner, S.E. Keating, M. Baran, K.A. Horan, S.B. Jensen, S. Sharma, C.M. Sirois, T. Jin, E. Latz, T.S. Xiao, K.A. Fitzgerald, S.R. Paludan, and A.G. Bowie IFI16 is an innate immune sensor for intracellular DNA Nat. Immunol. 11 2010 997 1004
24. N. Kerur, M.V. Veettil, N. Sharma-Walia, V. Bottero, S. Sadagopan, P. Otageri, and B. Chandran IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection Cell Host Microbe 9 2011 363 375
25. B.J. Ferguson, D.S. Mansur, N.E. Peters, H. Ren, and G.L. Smith DNA-PK is a DNA sensor for IRF-3-dependent innate immunity eLife 1 2012 e00047
26. Z. Zhang, B. Yuan, M. Bao, N. Lu, T. Kim, and Y.J. Liu The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells Nat. Immunol. 12 2011 959 965
27. Z. Zhang, T. Kim, M. Bao, V. Facchinetti, S.Y. Jung, A.A. Ghaffari, J. Qin, G. Cheng, and Y.J. Liu DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells Immunity 34 2011 866 978
28. O. Takeuchi, and S. Akira Innate immunity to virus infection Immunol. Rev. 227 2009 75 86
29. L.C. Platanias Mechanisms of type-I- and type-II-interferon-mediated signalling Nat. Rev. Immunol. 5 2005 375 386
30. H. Weidberg, and Z. Elazar TBK1 mediates crosstalk between the innate immune response and autophagy Sci. Signal. 4 2011 pe39
31. M. Pilli, J. Arko-Mensah, M. Ponpuak, E. Roberts, S. Master, M.A. Mandell, N. Dupont, W. Ornatowski, S. Jiang, S.B. Bradfute, J.A. Bruun, T.E. Hansen, T. Johansen, and V. Deretic TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation Immunity 37 2012 223 234
32. T.L. Thurston, G. Ryzhakov, S. Bloor, N. von Muhlinen, and F. Randow The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria Nat. Immunol. 10 2009 1215 1221
33. N. Mizushima, T. Yoshimori, and Y. Ohsumi The role of Atg proteins in autophagosome formation Annu. Rev. Cell. Dev. Biol. 27 2011 107 132
34. V. Deretic, and B. Levine Autophagy, immunity, and microbial adaptations Cell Host Microbe 5 2009 527 549
35. C. Richetta, and M. Faure Autophagy in antiviral innate immunity Cell Microbiol. 2012 10.1111/cmi.12043 [Epub ahead of print]
36. B. Yordy, and A. Iwasaki Autophagy in the control and pathogenesis of viral infection Curr. Opin. Virol. 1 2011 196 203
37. H.J. Kim, S. Lee, and J.U. Jung When autophagy meets viruses: a double-edged sword with functions in defense and offense Semin. Immunopathol. 32 2010 323 341
38. L. Galluzzi, O. Kepp, and G. Kroemer Autophagy and innate immunity ally against bacterial invasion EMBO J. 30 2011 3213 3214
39. P. Wild, H. Farhan, D.G. McEwan, S. Wagner, V.V. Rogov, N.R. Brady, B. Richter, J. Korac, O. Waidmann, C. Choudhary, V. Dotsch, D. Bumann, and I. Dikic Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth Science 333 2011 228 233
40. X. Ma, E. Helgason, Q.T. Phung, C.L. Quan, R.S. Iyer, M.W. Lee, K.K. Bowman, M.A. Starovasnik, and E.C. Dueber Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation Proc. Natl. Acad. Sci. USA 109 2012 9378 9383
41. A. Goncalves, T. Bürckstümmer, E. Dixit, R. Scheicher, M.W. Górna, E. Karayel, C. Sugar, A. Stukalov, T. Berg, R. Kralovics, M. Planyavsky, K.L. Bennett, J. Colinge, and G. Superti-Furga Functional dissection of the TBK1 molecular network PLoS One. 6 2011 e23971
42. C.Q. Lei, B. Zhong, Y. Zhang, J. Zhang, S. Wang, and H.B. Shu Glycogen synthase kinase 3β regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1 Immunity 33 2010 878 889
43. L.M. Sly, M.J. Rauh, J. Kalesnikoff, C.H. Song, and G. Krystal LPS induced upregulation of SHIP is essential for endotoxin tolerance Immunity 21 2004 227 239
44. H. An, H. Xu, M. Zhang, J. Zhou, T. Feng, C. Qian, R. Qi, and X. Cao Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism Blood 105 2005 4685 4692
45. J.N. Gabhann, R. Higgs, K. Brennan, W. Thomas, J.E. Damen, N. Ben Larbi, G. Krystal, and C.A. Jefferies Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-beta production J. Immunol. 184 2010 2314 2320
46. Y. Zhao, L. Liang, Y. Fan, S. Sun, L. An, Z. Shi, J. Cheng, W. Jia, W. Sun, Y. Mori-Akiyama, H. Zhang, S. Fu, and J. Yang PPM1B negatively regulates antiviral response via dephosphorylating TBK1 Cell Signal. 24 2012 2197 2204
47. C.E. McCoy, S. Carpenter, E.M. Pålsson-McDermott, L.J. Gearing, and L.A. O'Neill Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation J. Biol. Chem. 283 2008 14277 14285
48. S. Li, L. Wang, M. Berman, Y.Y. Kong, and M.E. Dorf Mapping a dynamic innate immunity protein interaction network regulating type I interferon production Immunity 35 2011 426 440
49. C. Wang, T. Chen, J. Zhang, M. Yang, N. Li, X. Xu, and X. Cao The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon Nat. Immunol. 10 2009 744 752
50. C.S. Friedman, M.A. O'Donnell, D. Legarda-Addison, A. Ng, W.B. Cárdenas, J.S. Yount, T.M. Moran, C.F. Basler, A. Komuro, C.M. Horvath, R. Xavier, and A.T. Ting The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response EMBO Rep. 9 2008 930 936
51. M. Zhang, X. Wu, A.J. Lee, W. Jin, M. Chang, A. Wright, T. Imaizumi, and S.C. Sun Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD J. Biol. Chem. 283 2008 18621 18626
52. K. Parvatiyar, G.N. Barber, and E.W. Harhaj TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases J. Biol. Chem. 285 2010 14999 15009
53. L. Gao, H. Coope, S. Grant, A. Ma, S.C. Ley, and E.W. Harhaj ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling J. Biol. Chem. 286 2011 36592 36602
54. S. Charoenthongtrakul, L. Gao, K. Parvatiyar, D. Lee, and E.W. Harhaj RING Finger Protein 11 Targets TBK1/IKKi Kinases to Inhibit Antiviral Signaling PLoS One. 8 2013 e53717
55. J. Cui, Y. Li, L. Zhu, D. Liu, Z. Songyang, H. Wang, and R. Wang NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4 Nat. Immunol. 13 2012 387 395
56. M. Zhang, L. Wang, X. Zhao, K. Zhao, H. Meng, W. Zhao, and C. Gao TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1 J. Exp. Med. 209 2012 1703 1711
57. M. Mori, M. Yoneyama, T. Ito, K. Takahashi, F. Inagaki, and T. Fujita Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation J. Biol. Chem. 279 2004 9698 9702
58. H. An, W. Zhao, J. Hou, Y. Zhang, Y. Xie, Y. Zheng, H. Xu, C. Qian, J. Zhou, Y. Yu, S. Liu, G. Feng, and X. Cao SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production Immunity 25 2006 919 928
59. H.S. Youn, J.Y. Lee, K.A. Fitzgerald, H.A. Young, S. Akira, and D.H. Hwang Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex J. Immunol. 175 2005 3339 3346
60. S.J. Park, and H.S. Youn Isoliquiritigenin suppresses the Toll-interleukin-1 receptor domain-containing adapter inducing interferon-beta (TRIF)-dependent signaling pathway of Toll-like receptors by targeting TBK1 J. Agric. Food. Chem. 58 2010 4701 4705
61. S.J. Park, A.N. Lee, and H.S. Youn TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin Arch. Pharm. Res. 33 2010 939 945
62. M.H. Ng, T.H. Ho, K.H. Kok, K.L. Siu, J. Li, and D.Y. Jin MIP-T3 is a negative regulator of innate type I IFN response J. Immunol. 187 2011 6473 6482
63. J. Huang, T. Liu, L.G. Xu, D. Chen, Z. Zhai, and H.B. Shu SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways EMBO J. 24 2005 4018 4028
64. Y. Li, C. Li, P. Xue, B. Zhong, A.P. Mao, Y. Ran, H. Chen, Y.Y. Wang, F. Yang, and H.B. Shu ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response Proc. Natl. Acad. Sci. USA 106 2009 7945 7950
65. S. Morton, L. Hesson, M. Peggie, and P. Cohen Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma FEBS Lett. 582 2008 997 1002
66. J. Mankouri, R. Fragkoudis, K.H. Richards, L.F. Wetherill, M. Harris, A. Kohl, R.M. Elliott, and A. Macdonald Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection PLoS Pathog. 6 2010 e1000778
67. C.E. Gleason, A. Ordureau, R. Gourlay, J.S. Arthur, and P. Cohen Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β J. Biol. Chem. 286 2011 35663 35674
68. K.E. Taylor, and K.L. Mossman Recent advances in understanding viral evasion of type I interferon Immunology 2012 10.1111/imm.12038 [Epub ahead of print]
69. D. Wang, L. Fang, P. Li, L. Sun, J. Fan, Q. Zhang, R. Luo, X. Liu, K. Li, H. Chen, Z. Chen, and S. Xiao The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase J. Virol. 85 2011 3758 3766
70. D. Zheng, G. Chen, B. Guo, G. Cheng, and H. Tang PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production Cell Res. 18 2008 1105 1113
71. G. Wang, G. Chen, D. Zheng, G. Cheng, and H. Tang PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway PLoS One 6 2011 e17192
72. M. Otsuka, N. Kato, M. Moriyama, H. Taniguchi, Y. Wang, N. Dharel, T. Kawabe, and M. Omata Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses Hepatology 41 2005 1004 1012
73. D. Verpooten, Y. Ma, S. Hou, Z. Yan, and B. He Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1 J. Biol. Chem. 284 2009 1097 1105
74. Y. Ma, H. Jin, T. Valyi-Nagy, Y. Cao, Z. Yan, and B. He Inhibition of TANK binding kinase 1 by herpes simplex virus 1 facilitates productive infection J. Virol. 86 2012 2188 2196
75. M. Sasai, M. Shingai, K. Funami, M. Yoneyama, T. Fujita, M. Matsumoto, and T. Seya NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction J. Immunol. 177 2006 8676 8683
76. B. Guo, and G. Cheng Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK J. Biol. Chem. 282 2007 11817 11826
77. G. Ryzhakov, and F. Randow SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK EMBO J. 26 2007 3180 3190
78. W. Zhao, L. Wang, M. Zhang, P. Wang, C. Yuan, J. Qi, H. Meng, and C. Gao Tripartite motif-containing protein 38 negatively regulates TLR3/4- and RIG-I-mediated IFN-β production and antiviral response by targeting NAP1 J. Immunol. 188 2012 5311 5318
79. L. Unterholzner, R.P. Sumner, M. Baran, H. Ren, D.S. Mansur, N.M. Bourke, F. Randow, G.L. Smith, and A.G. Bowie Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7 PLoS Pathog. 7 2011 e1002247
80. M. Schröder, M. Baran, and A.G. Bowie Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation EMBO J. 27 2008 2147 2157
81. K.L. Siu, K.H. Kok, M.H. Ng, V.K. Poon, K.Y. Yuen, B.J. Zheng, and D.Y. Jin Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex J. Biol. Chem. 284 2009 16202 16209
82. P.J. Alff, I.N. Gavrilovskaya, E. Gorbunova, K. Endriss, Y. Chong, E. Geimonen, N. Sen, N.C. Reich, and E.R. Mackow The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses J. Virol. 80 2006 9676 9686
83. P.J. Alff, N. Sen, E. Gorbunova, I.N. Gavrilovskaya, and E.R. Mackow The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation J. Virol. 82 2008 9115 9122
84. V. Matthys, E.E. Gorbunova, I.N. Gavrilovskaya, T. Pepini, and E.R. Mackow The C-terminal 42 residues of the Tula virus Gn protein regulate interferon induction J. Virol. 85 2011 4752 4760
85. G. Unterstab, S. Ludwig, A. Anton, O. Planz, B. Dauber, D. Krappmann, G. Heins, C. Ehrhardt, and T. Wolff Viral targeting of the interferon-{beta}- inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1 Proc. Natl. Acad. Sci. USA 102 2005 13640 13645
86. F.X. Zhu, S.M. King, E.J. Smith, D.E. Levy, and Y. Yuan A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation Proc. Natl. Acad. Sci. USA 99 2002 5573 5578
87. Q. Liang, B. Fu, F. Wu, X. Li, Y. Yuan, and F. Zhu ORF45 of Kaposi's sarcoma-associated herpesvirus inhibits phosphorylation of interferon regulatory factor 7 by IKKε and TBK1 as an alternative substrate J. Virol. 86 2012 10162 10172
88. G. DiPerna, J. Stack, A.G. Bowie, A. Boyd, G. Kotwal, Z. Zhang, S. Arvikar, E. Latz, K.A. Fitzgerald, and W.L. Marshall Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors J. Biol. Chem. 279 2004 36570 36578
89. P. Kaukinen, M. Sillanpää, L. Nousiainen, K. Melén, and I. Julkunen Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions J. Med. Virol. 85 2013 71 82
90. R.I. Feldman, J.M. Wu, M.A. Polokoff, M.J. Kochanny, H. Dinter, D. Zhu, S.L. Biroc, B. Alicke, J. Bryant, S. Yuan, B.O. Buckman, D. Lentz, M. Ferrer, M. Whitlow, M. Adler, S. Finster, Z. Chang, and D.O. Arnaiz Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1 J. Biol. Chem. 280 2005 19867 19874
91. T. Wang, M.A. Block, S. Cowen, A.M. Davies, E. Devereaux, L. Gingipalli, J. Johannes, N.A. Larsen, Q. Su, J.A. Tucker, D. Whitston, J. Wu, H.J. Zhang, M. Zinda, and C. Chuaqui Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKepsilon kinases Bioorg. Med. Chem. Lett. 22 2012 2063 2069
92. K. Clark, L. Plater, M. Peggie, and P. Cohen Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation J. Biol. Chem. 284 2009 14136 14146
93. J.E. Hutti, M.A. Porter, A.W. Cheely, L.C. Cantley, X. Wang, D. Kireev, A.S. Baldwin, and W.P. Janzen Development of a high-throughput assay for identifying inhibitors of TBK1 and IKKε PLoS One 7 2012 e41494
94. E.G. McIver, J. Bryans, K. Birchall, J. Chugh, T. Drake, S.J. Lewis, J. Osborne, E. Smiljanic-Hurley, W. Tsang, A. Kamal, A. Levy, M. Newman, D. Taylor, J.S. Arthur, K. Clark, and P. Cohen Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases Bioorg. Med. Chem. Lett. 22 2012 7169 7173
95. Laird, A.D., Vajkoczy, P., Shawver, L.K., Thurnher, A., Liang, C., Mohammadi, M., Schlessinger, J., Ullrich, A., Hubbard, S.R., Blake, R.A., Fong, T.A., Strawn, L.M., Sun, L., Tang, C., Hawtin, R., Tang, F., Shenoy, N., Hirth, K.P., McMahon, G. and Cherrington. (2000) SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res. 60, 4152-4162.
96. K. Godl, O.J. Gruss, J. Eickhoff, J. Wissing, S. Blencke, M. Weber, H. Degen, D. Brehmer, L. Orfi, Z. Horváth, G. Kéri, S. Müller, M. Cotton, A. Ullrich, and H. Daub Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling Cancer Res. 65 2005 6919 6926
97. D.F. Lee, and M.C. Hung Advances in targeting IKK and IKK-related kinases for cancer therapy Clin. Cancer. Res. 14 2008 5656 5662
98. R.O. Watson, P.S. Manzanillo, and J.S. Cox Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway Cell Signal. 150 2012 803 815
99. A.L. Radtke, L.M. Delbridge, S. Balachandran, G.N. Barber, and M.X. O'Riordan TBK1 protects vacuolar integrity during intracellular bacterial infection PLoS Pathog. 3 2007 e29
100. M. Bonnard, C. Mirtsos, S. Suzuki, K. Graham, J. Huang, M. Ng, A. Itié, A. Wakeham, A. Shahinian, W.J. Henzel, A.J. Elia, W. Shillinglaw, T.W. Mak, Z. Cao, and W.C. Yeh Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription EMBO J. 19 2000 4976 4985
101. Y. Chien, S. Kim, R. Bumeister, Y.M. Loo, S.W. Kwon, C.L. Johnson, M.G. Balakireva, Y. Romeo, L. Kopelovich, M. Gale Jr., C. Yeaman, J.H. Camonis, Y. Zhao, and M.A. White RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival Cell Signal. 127 2006 157 170
102. M. Delhase, S.Y. Kim, H. Lee, A. Naiki-Ito, Y. Chen, E.R. Ahn, K. Murata, S.J. Kim, N. Lautsch, K.S. Kobayashi, T. Shirai, M. Karin, and M. Nakanishi TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2 Proc. Natl. Acad. Sci. USA 109 2012 E177 186
103. J.F. Clément, S. Meloche, and M.J. Servant The IKK-related kinases: from innate immunity to oncogenesis Cell Res. 18 2008 889 899
104. Y.H. Ou, M. Torres, R. Ram, E. Formstecher, C. Roland, T. Cheng, R. Brekken, R. Wurz, A. Tasker, T. Polverino, S.L. Tan, and M.A. White TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation Mol. Cell. 41 2011 458 470
105. C. Korherr, H. Gille, R. Schäfer, K. Koenig-Hoffmann, J. Dixelius, K.A. Egland, I. Pastan, and U. Brinkmann Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway Proc. Natl. Acad. Sci. USA 103 2006 4240 4245
106. J. Jin, Y. Xiao, J. Chang, J. Yu, H. Hu, R. Starr, G.C. Brittain, M. Chang, X. Cheng, and S. Sun The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling Nat. Immunol. 13 2012 1101 1109
107. R.R. Shen, and W.C. Hahn Emerging roles for the non-canonical IKKs in cancer Oncogene 30 2011 631 641
108. D. Hammaker, D.L. Boyle, and G.S. Firestein Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis Rheumatology 51 2012 610 618
109. E. Niederberger, C. Möser, K. Kynast, and G. Geisslinger The non-canonical IκB kinases IKKε and TBK1 as potential targets for the development of novel therapeutic drugs Curr. Mol. Med. 2012 [Epub ahead of print]